Across the lifespan, chronically low calcium intake has been linked to higher blood pressure, in part because calcium plays a key role in vascular smooth‑muscle contraction, sodium handling, and endothelial function. Large epidemiologic studies and randomized trials suggest that individuals with higher dietary calcium intake tend to have modestly lower systolic and diastolic blood pressures and may experience a small but meaningful reduction in risk of stroke and other cardiovascular events. The practical takeaway is that maintaining adequate daily calcium, alongside blood pressure control, exercise, and a heart‑healthy diet, may be an underutilized strategy to support vascular health and reduce long‑term cardiovascular risk. This medication is commonly used for Hypertension.
Kim MH, Bu SY, Choi MK. Daily calcium intake and its relation to blood pressure, blood lipids, and oxidative stress biomarkers in hypertensive and normotensive subjects. Nutr Res Pract. 2012 Oct;6(5):421-8. Hamer O, Mohamed A, Ali-Heybe Z, Schnieder E, Hill JE. Calcium supplementation for the prevention of hypertension: a synthesis of existing evidence and implications for practise. Br J Card Nurs. 2024 Feb 24;19(2):0010. Cheng, L., Lian, J., Ding, Y., Wang, X., Munir, M. A. M., Ullah, S., Wang, E., He, Z., & Yang, X. (2024). Calcium deficiency and its implications for cardiovascular disease and cancer: Strategies for resolution via agronomic fortification. Food Science & Nutrition, 12, 8594–8607.
Some side effects may be linked to nutrient depletion caused by this medication.
Studies suggest that Felodipine, a type of calcium channel blocker (CCB), may increase the excretion of calcium in the urine. While the long-term effects on bone health are unclear, some healthcare professionals suggest calcium supplementation for patients taking felodipine, especially those at higher risk of osteoporosis.
Research suggests that Felodipine, a type of calcium channel blocker (CCB), may increase the excretion of magnesium in the urine. This can potentially lead to magnesium deficiency. Studies have shown an increase in fractional excretion of magnesium following felodipine treatment, and the drug may also alter how magnesium moves across red blood cell membranes. Therefore supplementation with magnesium should be considered when on this therapy.
An increased excretion of potassium can occur in people taking calcium channel blocker drugs like felodipine. Supplementation may need to be considered if blood levels of potassium are low.